| PHOSPHONIC ACID, [[[1-[(2-AMINO-9H-PURIN-9-YL)METHYL]CYCLOPROPYL]OXY]METHYL]- (9CI) |
P-[[[1-[(2-氨基-9H-嘌呤-9-基)甲基]环丙基]氧基]甲基]-磷酸 |
441785-25-7 |
| 6-(1H-indol-4-yl)-4-(5-((4-isopropylpiperazin-1-yl)methyl)oxazol-2-yl)-1H-indazole |
CS-2340 |
1254036-71-9 |
| Porcupine-IN-1 |
Porcupine-IN-1 |
2036044-77-4 |
| Propargyl-PEG8-acid |
丙炔基-七聚乙二醇-羧酸 |
2055014-94-1 |
| RO 5028442 |
RO 5028442 |
920022-47-5 |
| MK-8353 |
化合物 T12069 |
1184173-73-6 |
| CPI-1189 |
N-叔丁基-4-乙酰氨基苯甲酰胺 |
183619-38-7 |
| Propargyl-PEG4-t-butyl ester |
丙炔基-三聚乙二醇-丙酸叔丁酯 |
1355197-66-8 |
| AriMocloMol Maleic Acid |
289893-26-1 |
289893-26-1 |
| PI3Kα inhibitor 1 |
PI3Kα 抑制剂1 |
1235449-52-1 |
| LDN 193189 hydrochloride |
LDN-193189 2HCL |
1435934-00-1 |
| 2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide |
2,2′,2′-[1,3,5-Triazine-2,4,6-triyltris(oxy-4,1-phenylenecarbonyloxy)]tris[N,N,N-trimethyl-ethanaminium tri-iodide |
1414469-59-2 |
| 3,4-Dimethoxy-N-(5-phenyl-1H-pyrazol-3-yl)-benzamide |
3,4-二甲氧基-N-(5-苯基-1H-吡唑-3-基)苯甲酰胺 |
942655-44-9 |
| Shield-1 |
化合物SHIELD-1 |
914805-33-7 |
| TranylcyproMine (2-PCPA) HCl |
(1S,2R)-2-苯基-环丙胺盐酸盐 |
4548-34-9 |
| Saroglitazar |
沙罗格列扎 |
495399-09-2 |
| 9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE HYDRATE,99+% |
9-氨基-1,2,3,4-四氢吖啶 盐酸盐 水合物 |
206658-92-6 |
| SGA 293 |
SGA360 |
680611-86-3 |
| Tipifarnib (S enantioMer) |
192185-71-0 |
192185-71-0 |
| 9a-(4-chlorobenzyl)-7-hydroxy-4-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-1,2,9,9a-tetrahydro-3H-fluoren-3-one |
CMP8 |
851107-28-3 |
